The FINANCIAL — Janssen Research & Development, LLC announced the U.S. Food and Drug Administration (FDA) has assigned a priority review designation to the supplemental New Drug Applications filed on ...
Drug regulators said an experimental stroke preventer from Bayer and Johnson & Johnson is not ready for approval and raised questions about its effectiveness, sending Bayer shares down more than 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback